AUTHOR=Combemale Loraine , Bohelay Gérôme , Sitbon Ishaï-Yaacov , Ahouach Btisseme , Alexandre Marina , Martin Antoine , Pascal Francis , Soued Isaac , Doan Serge , Morin Florence , Grootenboer-Mignot Sabine , Caux Frédéric , Prost-Squarcioni Catherine , Le Roux-Villet Christelle TITLE=Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review JOURNAL=Frontiers in Immunology VOLUME=15 YEAR=2024 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1243566 DOI=10.3389/fimmu.2024.1243566 ISSN=1664-3224 ABSTRACT=Background

Lichen planus pemphigoides (LPP), an association between lichen planus and bullous pemphigoid lesions, is a rare subepithelial autoimmune bullous disease. Mucous membrane involvement has been reported previously; however, it has never been specifically studied.

Methods

We report on 12 cases of LPP with predominant or exclusive mucous membrane involvement. The diagnosis of LPP was based on the presence of lichenoid infiltrates in histology and immune deposits in the basement membrane zone in direct immunofluorescence and/or immunoelectron microscopy. Our systematic review of the literature, performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, highlights the clinical and immunological characteristics of LPP, with or without mucous membrane involvement.

Results

Corticosteroids are the most frequently used treatment, with better outcomes in LPP with skin involvement alone than in that with mucous membrane involvement. Our results suggest that immunomodulators represent an alternative first-line treatment for patients with predominant mucous membrane involvement.